STXS Stereotaxis Inc.
Stereotaxis Inc. (STXS) is expected to report earnings on February 9, 2027, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.2% since its last earnings release on November 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Stereotaxis Inc.
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.